USP comments to FDA on CDER DER’s Program for the Recognition of Voluntary Consensus Standards Related to Pharmaceutical Quality (2019)

USP comments to FDA on Docket No. FDA-2018-D-4417 for “CDER’s Program for the Recognition of Voluntary Consensus Standards Related to Pharmaceutical Quality.” Comments were submitted in 2019.

USP-comments-to-FDA-on-CDER-voluntary-consensus-standards-guidance.pdf (167.72 KB)

Public Policy